💥🇺🇸#VRTX Vertex Pharmaceuticals stock price target raised to $305 from $281 at J.P. Morgan💥🇺🇸#SGEN Seattle Genetics stock price target raised to $179 from $150 at J.P. Morgan💥🇺🇸#LRCX Lam Research stock price target raised to $435 from $270 at B. Riley FBR⚠️🇺🇸#BIIB Biogen stock price target cut to $272 from $293 at J.P. Morgan💥🇺🇸#PYPD POLYPID started at OUTPERFORM with $23 stock price target at Raymond James💥🇺🇸#EXK ENDEAVOUR SILVER started at BUY with $4.75 stock price target at B. Riley FBR⚠️🇺🇸#FNHC FEDNAT downgraded to OUTPERFORM from STRONG BUY at Raymond James⚠️🇺🇸#NDAQ NASDAQ downgraded to MARKET PERFORM from OUTPERFORM at Raymond James
Акции США
NDAQ
NASDAQ понижен до 'Market Perform'
NASDAQ понижен до уровня 'Market Perform' от Raymond James.
Контекст по активу
Nasdaq, Inc. (NDAQ). Бумага относится к сектору "Финансы". Последняя цена: 98,73 USD. Текущая дневная динамика: 0%. Актив есть в портфелях 77 пользователей FinPlan. Капитализация около 48,5 млрд USD.